arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Dare Bioscience, Inc.

DARE

$0.81 ▼ -0.06 (-7.17%) at close

15 Visible periods

26 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Dare Bioscience, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $9.1M

Dividend Yield —

Revenue Growth 10429.4% ↗

Op. Margin None

ROIC -476.8% ↘

FCF / Share $-0.92 ↘

Trailing P/E —

Price / Book 4.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.03M

↑ +10429.4% —

Net Income Profit after all expenses

$-13.40M

↓ -230.6% —

FCF / Share Free cash flow per share

$-0.92

↓ -259.3% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -476.8% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.77x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue Growth YoY (%)	10429.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+130267%)	-99.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1346%)	-71.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-999%)	—	—	—	—	—	—	—	—	1233.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15317%)	-99.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1338%)	—	—
EPS Growth YoY (%)	-150.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	88.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	6.6% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	41.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	30.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-230.6% Weak ↓ Weak Declining Year-over-year change in net income	86.6% Excellent ↑ Excellent Improving Year-over-year change in net income	2.5% Caution ↑ Caution Improving Year-over-year change in net income	20.0% Good ↑ Good Improving Year-over-year change in net income	-41.2% Weak → Weak Stable Year-over-year change in net income	-92.1% Weak ↓ Weak Declining Year-over-year change in net income	14.8% Fair ↑ Fair Improving Year-over-year change in net income	-45.5% Weak ↓ Weak Declining Year-over-year change in net income	70.7% Excellent ↑ Excellent Improving Year-over-year change in net income	0.7% Caution ↑ Caution Improving Year-over-year change in net income	-69.6% Weak ↓ Weak Declining Year-over-year change in net income	-36.2% Weak Weak Year-over-year change in net income	22.4% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	N/M	-110.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	54.4% Excellent Excellent Year-over-year change in free cash flow	43.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-53.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	403.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Operating Margin (%) (%)	—	—	—	-313.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2192%)	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	-309.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2679%)	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	-181.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-1.21x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.22x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	-476.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	390.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	613.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	-282.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-100.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	2379.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-2570.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-198.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-66.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—
Return on Capital (%) (%)	-41.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-106.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-145.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-71.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-70.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-362.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-192.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-215.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-78.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	—	67.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+349%)	—	-278.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1957%)	-99.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-766%)	—	—	-248.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1759%)	-86.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-677%)	-299.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2099%)	-81.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-642%)	-51.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-443%)	18.2% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+21%)	27.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+84%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Net Debt (USD)	$-24.71M	$-15.70M	$-10.48M	$-34.67M	$-51.67M	$-4.67M	$-4.78M	$-6.81M	$-7.56M	$-34.95M	$-75.91M	$-51.17M	$-5.49M	$-16.71M	$-15.35M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue per Share (USD)	$0.09	$0.00	$0.39	$1.42	$0.00	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.20	$-0.48	$-4.15	$-4.44	$-7.56	$-10.92	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.92	$0.58	$-5.43	$-2.58	$-5.65	$-10.07	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.20	$-0.69	$-0.61	$1.57	$5.54	$-0.33	$0.27	$70.70	$263.89	$543.92	$2.14K	$2.70K	—	—	—
Tangible Book Value per Share (USD)	$0.20	$-0.69	$-0.61	$1.57	$5.54	$-0.33	$0.27	$70.70	$11.77	$543.92	$2.14K	$2.70K	—	—	—
Basic Weighted Avg Shares (shares)	11.18M	8.50M	7.28M	7.04M	5.09M	2.51M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$3.38M	$-3.17M	$-2.94M	$11.41M	$39.24M	$-676.69K	$831.53K	$6.15M	$7.38M	$19.85M	$60.97M	$44.77M	$-8.70M	—	—
Total Equity (USD)	$2.84M	$-6.01M	$-5.05M	$11.11M	$38.75M	$-1.15M	$440.83K	$6.73M	$13.29M	$13.11M	$48.74M	$45.33M	$-94.30M	$-80.04M	$-58.40M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$1.03M	$9.78K	$2.81M	$10.00M	$0.00	—	—	—	—	$766.00K	—	$80.00K	$6.00K	$625.00K	—
Depreciation Expense (USD)	$1.63M	$42.33K	$38.36K	$24.20K	$26.41K	$43.23K	$11.14K	$2.44K	$0.00	$261.00K	$192.00K	$126.00K	$197.00K	$346.00K	—
Net Income, GAAP (USD)	$-13.40M	$-4.05M	$-30.16M	$-30.95M	$-38.70M	$-27.40M	$-14.26M	$-16.74M	$-11.50M	$-39.30M	$-39.59M	$-23.34M	$-17.14M	$-22.10M	—
Operating Cash Flow (USD)	$-9.89M	$5.47M	$-38.86M	$-18.09M	$-28.76M	$-25.23M	$-13.32M	$-10.27M	$-2.54M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 15 years · 56 quarters

Dare Bioscience, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare DARE with peers